Stroke
Conference Coverage
Prediabetes linked to higher CVD and CKD rates
Data from more than 330,000 U.K. adults show that an A1c of 5.7%-6.4% links with higher rates of incident CKD and CVD events.
Conference Coverage
Single subcutaneous shot offers fast, potent platelet inhibition in STEMI
The effect was seen within 15 minutes of receiving RUC-4, an investigational glycoprotein IIb/IIIa inhibitor, with no thrombocytopenia, in a phase...
Guidelines
New AHA/ASA guideline on secondary stroke prevention
Identifying the cause of a first stroke or transient ischemic attack is key to developing strategies to prevent repeat events, the AHA/ASA says in...
From the Journals
Large vessel stroke linked to AstraZeneca COVID vaccine
Three cases occurred in two women and one man in their 30s or 40s and involved blockages of the carotid and middle cerebral artery.
From the Journals
Final SPRINT data confirm lower BP is better
The new results are “more robust,” says expert.
Conference Coverage
LAAOS III: Surgical LAA closure cuts AFib stroke risk by one-third
The finding ‘opens a new paradigm’ for stroke prevention in atrial fibrillation and should change clinical guidelines, experts say.
Conference Coverage
ADAPTABLE: Low-dose aspirin as good as high-dose in CHD?
A large randomized trial specifically designed to investigate the optimum dose of aspirin in patients with established coronary disease has found...
From the Journals
High teen BMI linked to stroke risk in young adulthood
Finding holds true for men and women, even for those individuals with BMIs in the high-normal range.
News
FDA class I recall for some Cordis carotid stent systems
A total of 7,300 Precise PRO Rx carotid stent systems are being recalled in the United States due to a risk of separation of the distal tip of the...
Conference Coverage
Modest clinical gain for AF screening of asymptomatic elderly: STROKESTOP
Literally all known 75- and 76-year-olds in two Swedish regions were included, whether or not they were screened by mobile ECG recorder. But does...
From the Journals
AHA statement flags CV risk of hormonal cancer therapies
The American Heart Association outlines cardiovascular risks associated with hormonal therapies for breast and prostate cancer and provides...